Treatment of schizoaffective disorder

Elisa Cascade, Amir H. Kalali, Peter Buckley

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

In this article, we investigate the range of treatments prescribed for schizoaffective disorder. The data show that the majority of those treated, 87 percent, receive two or more pharmaceutical classes. From a therapeutic class perspective, 93 percent of schizoaffective disorder patients receive an antipsychotic, 48 percent receive a mood disorder treatment, and 42 percent receive an antidepressant. An expert commentary is also included.

Original languageEnglish (US)
Pages (from-to)15-17
Number of pages3
JournalPsychiatry
Volume6
Issue number3
StatePublished - Aug 14 2009

Fingerprint

Psychotic Disorders
Mood Disorders
Antidepressive Agents
Antipsychotic Agents
Therapeutics
Pharmaceutical Preparations

Keywords

  • Antidepressant
  • Antipsychotic
  • Schizoaffective disorder

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Cascade, E., Kalali, A. H., & Buckley, P. (2009). Treatment of schizoaffective disorder. Psychiatry, 6(3), 15-17.

Treatment of schizoaffective disorder. / Cascade, Elisa; Kalali, Amir H.; Buckley, Peter.

In: Psychiatry, Vol. 6, No. 3, 14.08.2009, p. 15-17.

Research output: Contribution to journalArticle

Cascade, E, Kalali, AH & Buckley, P 2009, 'Treatment of schizoaffective disorder', Psychiatry, vol. 6, no. 3, pp. 15-17.
Cascade E, Kalali AH, Buckley P. Treatment of schizoaffective disorder. Psychiatry. 2009 Aug 14;6(3):15-17.
Cascade, Elisa ; Kalali, Amir H. ; Buckley, Peter. / Treatment of schizoaffective disorder. In: Psychiatry. 2009 ; Vol. 6, No. 3. pp. 15-17.
@article{a06e484043d04079a0a85028aa57633c,
title = "Treatment of schizoaffective disorder",
abstract = "In this article, we investigate the range of treatments prescribed for schizoaffective disorder. The data show that the majority of those treated, 87 percent, receive two or more pharmaceutical classes. From a therapeutic class perspective, 93 percent of schizoaffective disorder patients receive an antipsychotic, 48 percent receive a mood disorder treatment, and 42 percent receive an antidepressant. An expert commentary is also included.",
keywords = "Antidepressant, Antipsychotic, Schizoaffective disorder",
author = "Elisa Cascade and Kalali, {Amir H.} and Peter Buckley",
year = "2009",
month = "8",
day = "14",
language = "English (US)",
volume = "6",
pages = "15--17",
journal = "Psychiatry",
issn = "2158-8333",
publisher = "Matrix Medical Communications",
number = "3",

}

TY - JOUR

T1 - Treatment of schizoaffective disorder

AU - Cascade, Elisa

AU - Kalali, Amir H.

AU - Buckley, Peter

PY - 2009/8/14

Y1 - 2009/8/14

N2 - In this article, we investigate the range of treatments prescribed for schizoaffective disorder. The data show that the majority of those treated, 87 percent, receive two or more pharmaceutical classes. From a therapeutic class perspective, 93 percent of schizoaffective disorder patients receive an antipsychotic, 48 percent receive a mood disorder treatment, and 42 percent receive an antidepressant. An expert commentary is also included.

AB - In this article, we investigate the range of treatments prescribed for schizoaffective disorder. The data show that the majority of those treated, 87 percent, receive two or more pharmaceutical classes. From a therapeutic class perspective, 93 percent of schizoaffective disorder patients receive an antipsychotic, 48 percent receive a mood disorder treatment, and 42 percent receive an antidepressant. An expert commentary is also included.

KW - Antidepressant

KW - Antipsychotic

KW - Schizoaffective disorder

UR - http://www.scopus.com/inward/record.url?scp=68349146466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68349146466&partnerID=8YFLogxK

M3 - Article

C2 - 19724749

AN - SCOPUS:68349146466

VL - 6

SP - 15

EP - 17

JO - Psychiatry

JF - Psychiatry

SN - 2158-8333

IS - 3

ER -